Description | This product is a human antibody that specifically targets human SNCA. It attaches to α-syn residues 1-10. It exhibits a remarkable preference for aggregated forms of α-syn, displaying an apparent affinity that is at least 800 times higher for fibrillar α-syn compared to monomeric recombinant α-syn. Furthermore, it demonstrates a strong affinity for human PD brain tissue, effectively distinguishing between monomers and oligomeric/fibrillar forms of α-syn due to its high avidity for aggregates. This avidity is a result of its weak monovalent affinity and rapid binding kinetics. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | Human |
Epitope | AA 1-10 |
Affinity | KD = 120 pM |
Isotype | Human IgG |
Expression Species | HEK293F or CHO |
Conjugation | None |
Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
Endotoxin | <1 EU/mg |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
Application | ELISA; FuncS; IHC; DB |
Application Notes | IHC: 2-8 μg/mL Dot blot: 1.25 μg/mL |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |